Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE).
- DOI
- 10.1002/jia2.26003
- Published
- 2022 Sep
- Container
- Journal of the International AIDS Society
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/jia2.26003,
title = {Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE).},
author = {Czarnogorski M and Garris CP and Dalessandro M and D'Amico R and Nwafor T and Williams W and Merrill D and Wang Y and Stassek L and Wohlfeiler MB and Sinclair GI and Mena LA and Thedinger B and Flamm JA and Benson P and Spreen WR},
year = {2022},
journal = {Journal of the International AIDS Society},
doi = {10.1002/jia2.26003},
url = {https://doi.org/10.1002/jia2.26003}
}RIS
TY - JOUR TI - Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE). AU - Czarnogorski M AU - Garris CP AU - Dalessandro M AU - D'Amico R AU - Nwafor T AU - Williams W AU - Merrill D AU - Wang Y AU - Stassek L AU - Wohlfeiler MB AU - Sinclair GI AU - Mena LA AU - Thedinger B AU - Flamm JA AU - Benson P AU - Spreen WR PY - 2022 JO - Journal of the International AIDS Society DO - 10.1002/jia2.26003 UR - https://doi.org/10.1002/jia2.26003 ER -
APA
M, C., CP, G., M, D., R, D., T, N., W, W., D, M., Y, W., L, S., MB, W., GI, S., LA, M., B, T., JA, F., P, B., & WR, S. (2022). Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE).. Journal of the International AIDS Society. https://doi.org/10.1002/jia2.26003
Source records
- pubmed · retrieved 2026-09-27T00:59:39.087Z